Public Market Listing
069620KOSPI
Live quotes, historical charts, and market capitalization for Daewoong Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(5 total)
5Total Assets
0Approved
4Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Undisclosed / early pipelineSmall molecule | HypertensionAtherosclerotic Cardiovascular Disease | |
DWJ1276No recent activity | Phase 3 | Angiotensin II receptor / HMG-CoA reductaseSmall molecule | Hypertension |
DWP16001(Enavogliflozin) | Phase 3 | SGLT2Small molecule | Type 2 Diabetes |
OLOMAXNo recent activity | Phase 3 | Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule | Atherosclerotic Cardiovascular Disease |
| Phase 1 | GLP-1 receptorPeptide | Obesity |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.